+ All Categories
Home > Documents > Making Cost Savings Count - radiologysolutions.bayer.com...Bayer HealthCare LLC 100 Bayer Boulevard...

Making Cost Savings Count - radiologysolutions.bayer.com...Bayer HealthCare LLC 100 Bayer Boulevard...

Date post: 26-Jan-2021
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
4
Making Cost Savings Count Upgrading to MEDRAD® Stellant FLEX CT Injection System Drives Cost Efficiencies and Standardization for Windsong Radiology Group Key Takeaways Windsong Radiology Group is a New York-based radiology practice with five locations. Recently, Windsong participated in a controlled commercial release (CCR) of the MEDRAD® Stellant FLEX CT Injection System, the newest MEDRAD CT Injection System. Their participation allowed them to examine how the technology could improve their existing processes while lending their input to Bayer ahead of the company’s widespread platform release. Following the CCR, Windsong detailed how the MEDRAD® Stellant FLEX CT Injection System and Bayer’s CT non-obsolescence program have been key to helping them minimize operational costs, standardize care and avoid downtime. Partnering with Bayer for their equipment needs allowed Windsong to achieve a number of primary metrics that are critical to their cost efficiency goals: Staying current with equipment at an affordable rate Maintaining reproducible and consistent image quality for “apples to apples comparisons” throughout a patient’s care journey Reducing operating costs Benefitting from continued product reliability and maximizing up-time Avoiding Obsolescence and Minimizing Downtime Healthcare is evolving, and Windsong, like other radiology centers across the country, is faced with the balancing act of providing high-quality, value-based care while also meeting their budgetary needs. Participating in the MEDRAD® Stellant FLEX CT Injection System CCR gave Windsong the ability to experience how the new CT injection system and TechCARE program are optimized to help imaging providers save on operational costs and limit downtime. When coupled with Bayer’s CT non-obsolescence program – which delivers all the benefits of Bayer Equipment Service -- MEDRAD® Stellant FLEX CT Injection System provided Windsong with the boost they needed to maximize their profits in the face of declining reimbursements. It also helped them affordably enact a future-proofed plan for staying up to date with the most current injection system technology. “One reason why we jumped on Bayer’s CT non-obsolescence program is because, for a very small sum, we were able to replace all of our injectors. We spent a fraction of what it would normally cost,” said An. “Bayer realizes where medical imaging is headed,” added An, reinforcing that Windsong’s partnership with Bayer allowed the practice to avoid obsolescence as they continue to grow and consider opening additional office locations. “Our biggest hurdle right now is declining reimbursements,” said Bryan An, Windsong’s supervisor of MRI and CT. “The cost of doing business has not gone down, but our reimbursements have.” Bryan An, Supervisor of CT and MRI, Windsong Radiology Group
Transcript
  • Making Cost Savings Count Upgrading to MEDRAD® Stellant FLEX CT Injection System Drives Cost Efficiencies and Standardization for Windsong Radiology Group

    Key Takeaways Windsong Radiology Group is a New York-based

    radiology practice with five locations. Recently, Windsong

    participated in a controlled commercial release (CCR)

    of the MEDRAD® Stellant FLEX CT Injection System, the

    newest MEDRAD CT Injection System. Their participation

    allowed them to examine how the technology could

    improve their existing processes while lending their input

    to Bayer ahead of the company’s widespread platform

    release. Following the CCR, Windsong detailed how the

    MEDRAD® Stellant FLEX CT Injection System and Bayer’s CT

    non-obsolescence program have been key to helping them

    minimize operational costs, standardize care and avoid

    downtime.

    Partnering with Bayer for their equipment needs allowed

    Windsong to achieve a number of primary metrics that are

    critical to their cost efficiency goals:

    • Staying current with equipment at an affordable rate• Maintaining reproducible and consistent image quality for “apples to apples comparisons”

    throughout a patient’s care journey

    • Reducing operating costs• Benefitting from continued product reliability and maximizing up-time

    Avoiding Obsolescence and Minimizing DowntimeHealthcare is evolving, and Windsong, like other radiology

    centers across the country, is faced with the balancing

    act of providing high-quality, value-based care while also

    meeting their budgetary needs.

    Participating in the MEDRAD®

    Stellant FLEX CT Injection System

    CCR gave Windsong the ability to

    experience how the new CT injection

    system and TechCARE program

    are optimized to help imaging

    providers save on operational costs

    and limit downtime. When coupled

    with Bayer’s CT non-obsolescence

    program – which delivers all the

    benefits of Bayer Equipment Service

    -- MEDRAD® Stellant FLEX CT

    Injection System provided Windsong with the boost they

    needed to maximize their profits in the face of declining

    reimbursements. It also helped them affordably enact a

    future-proofed plan for staying up to date with the most

    current injection system technology.

    “One reason why we jumped on

    Bayer’s CT non-obsolescence

    program is because, for a very small

    sum, we were able to replace all of

    our injectors. We spent a fraction

    of what it would normally cost,”

    said An. “Bayer realizes where

    medical imaging is headed,” added

    An, reinforcing that Windsong’s

    partnership with Bayer allowed the practice to avoid

    obsolescence as they continue to grow and consider

    opening additional office locations.

    “Our biggest hurdle

    right now is declining

    reimbursements,” said

    Bryan An, Windsong’s

    supervisor of MRI and

    CT. “The cost of doing

    business has not

    gone down, but our

    reimbursements have.”

    Bryan An, Supervisor of CT and MRI, Windsong Radiology Group

  • Capitalizing on ReliabilityWindsong chose to participate in the CCR for MEDRAD®

    Stellant FLEX CT Injection System due to their long-

    standing relationship with Bayer and the history of

    reliability with their MEDRAD injection

    systems. Sharing his personal

    experience, An credited the reliability

    of MEDRAD as a major reason that

    Windsong has been able to efficiently

    manage operational costs.

    “I’ve been using MEDRAD® injectors

    since 1998, and I can’t remember a time

    where we had any extended downtime

    because of an injector.” He added

    that when the practice was previously

    provided with a competitor’s injector at

    no cost, Windsong chose to return it due

    to inconsistent performance.

    Windsong’s CCR experience was a positive one, said An.

    “If asked by another provider, I would recommend the

    MEDRAD® Stellant FLEX because it’s a good product with

    high reliability, combined with great services provided by

    Bayer.”

    Overcoming Financial HurdlesCost has always been a major factor in healthcare, but

    the current landscape is making it more difficult than

    ever for providers to maintain cost efficiency. It’s a

    challenge that Windsong knows well and has worked

    hard to effectively manage.

    Meeting Needs in the Current ClimateMEDRAD® Stellant FLEX CT Injection System is designed

    to set providers up for success — both in terms of the

    radiology services they provide and their operational

    metrics. At Windsong, unique features

    like smaller syringes and improved

    loading have improved the practice’s

    workflow, as well as their ability

    to keep costs down over time. “The

    enhanced design of the MEDRAD®

    Stellant FLEX CT Injection System made

    the decision to upgrade easy,” said An,

    noting that the injection system allows

    them to consistently inject contrast

    and the importance of reproducibility.

    Windsong is far from alone in their

    need to choose equipment and services

    that align with their financial goals

    and challenges. An said that after

    working with the MEDRAD® Stellant FLEX CT Injection

    System firsthand he would recommend that other

    radiology practices make the switch.

    “You should treat your patients like your own family,

    and I would want my family to have a study done with

    a MEDRAD® injection system versus any other injector,”

    said An. He noted that as Windsong continues to expand

    their services, they plan to rely on Bayer’s comprehensive

    portfolio to ensure they provide the best possible care at

    the most reasonable cost.

    2

    “One reason why we

    jumped on Bayer’s CT non-

    obsolescence program is

    because, for a very small

    sum, we were able to

    replace all of our injectors.

    We spent a fraction of what

    it would normally cost,”

    said An. “Bayer realizes

    where medical imaging is

    headed,”

  • MEDRAD® Stellant FLEX CT Injection System Windsong Radiology Group

    3

    “We’ve experienced increased procedure

    volume in several modalities, yet

    our reimbursement has gone down

    significantly,” said An. “It’s an issue that’s

    all too familiar for radiology providers, and

    one that I believe Bayer is actively working

    on through their innovative portfolio

    offerings that can help customers control

    costs.”

  • PP-M

    -STE

    -F-U

    S-01

    00-1

    Ja

    nuar

    y 20

    20

    Bayer HealthCare LLC100 Bayer BoulevardP.O. Box 915Whippany, NJ 07981U.S.A.Phone: +1-412-767-2400 +1-800-633-7231Fax: +1-412-767-4120

    More information onradiologysolutions.bayer.com

    Bayer reserves the right to modify the specifications and features described herein or to discontinue any product or service identified in this publication at any time without prior notice or obligation. Please contact your authorized Bayer representative for the most current information.

    Patient Information listed on the Graphical User Interfaces are fictious examples only and do not contain any actual patient data.

    Bayer, the Bayer Cross, MEDRAD, MEDRAD Stellant, Stellant, MEDRAD Stellant FLEX, and Stellant FLEX are trademarks owned by and/or registered to Bayer in the U.S. and/or other countries. Other trademarks and company names mentioned herein are properties of their respective owners and are used herein solely for informational purposes. No relationship or endorsement should be inferred or implied.

    © 2019 Bayer. This material may not be reproduced, displayed, modified or distributed without the express prior written consent of Bayer.

    Manufacturer Bayer Medical Care Inc.1 Bayer DriveIndianola, PA 15051-0780U.S.A.Phone: +1-412-767-2400 +1-800-633-7231Fax: +1-412-767-4120


Recommended